NRF2 negatively regulates primary ciliogenesis and hedgehog signaling.
Animals
Antioxidant Response Elements
Cells, Cultured
Cilia
/ metabolism
Gene Expression
Gene Knockout Techniques
Hedgehog Proteins
/ antagonists & inhibitors
Humans
Inclusion Bodies
/ metabolism
Mice
Microtubule-Associated Proteins
/ metabolism
NF-E2-Related Factor 2
/ genetics
Patched-1 Receptor
/ genetics
Sequestosome-1 Protein
/ genetics
Signal Transduction
Journal
PLoS biology
ISSN: 1545-7885
Titre abrégé: PLoS Biol
Pays: United States
ID NLM: 101183755
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
11
06
2019
accepted:
22
01
2020
revised:
26
02
2020
pubmed:
14
2
2020
medline:
15
5
2020
entrez:
14
2
2020
Statut:
epublish
Résumé
Primary cilia are lost during cancer development, but the mechanism regulating cilia degeneration is not determined. While transcription factor nuclear factor-erythroid 2-like 2 (NRF2) protects cells from oxidative, proteotoxic, and metabolic stress in normal cells, hyperactivation of NRF2 is oncogenic, although the detailed molecular mechanisms by which uncontrolled NRF2 activation promotes cancer progression remain unclear. Here, we report that NRF2 suppresses hedgehog (Hh) signaling through Patched 1 (PTCH1) and primary ciliogenesis via p62/sequestosome 1 (SQSTM1). PTCH1, a negative regulator of Hh signaling, is an NRF2 target gene, and as such, hyperactivation of NRF2 impairs Hh signaling. NRF2 also suppresses primary cilia formation through p62-dependent inclusion body formation and blockage of Bardet-Biedl syndrome 4 (BBS4) entrance into cilia. Simultaneous ablation of PTCH1 and p62 completely abolishes NRF2-mediated inhibition of both primary ciliogenesis and Hh signaling. Our findings reveal a previously unidentified role of NRF2 in controlling a cellular organelle, the primary cilium, and its associated Hh signaling pathway and also uncover a mechanism by which NRF2 hyperactivation promotes tumor progression via primary cilia degeneration and aberrant Hh signaling. A better understanding of the crosstalk between NRF2 and primary cilia/Hh signaling could not only open new avenues for cancer therapeutic discovery but could also have significant implications regarding pathologies other than cancer, including developmental disorders, in which improper primary ciliogenesis and Hh signaling play a major role.
Identifiants
pubmed: 32053600
doi: 10.1371/journal.pbio.3000620
pii: PBIOLOGY-D-19-01674
pmc: PMC7043785
doi:
Substances chimiques
BBS4 protein, mouse
0
Hedgehog Proteins
0
Microtubule-Associated Proteins
0
NF-E2-Related Factor 2
0
NFE2L2 protein, human
0
PTCH1 protein, human
0
Patched-1 Receptor
0
SQSTM1 protein, human
0
Sequestosome-1 Protein
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e3000620Subventions
Organisme : NIEHS NIH HHS
ID : P30 ES006694
Pays : United States
Organisme : NIEHS NIH HHS
ID : P42 ES004940
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK109555
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES026845
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Mol Cell Biol. 2017 Mar 31;37(8):
pubmed: 28115426
Mol Cell Biol. 2004 Aug;24(16):7130-9
pubmed: 15282312
Cell. 2016 Apr 7;165(2):410-20
pubmed: 27020754
Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:555-575
pubmed: 30256716
Development. 1997 Apr;124(7):1313-22
pubmed: 9118802
Cancer Sci. 2018 Apr;109(4):900-911
pubmed: 29450944
Cancer Res. 2010 Jul 1;70(13):5486-96
pubmed: 20530669
Nat Rev Genet. 2010 May;11(5):331-44
pubmed: 20395968
Nat Med. 2017 Oct;23(10):1191-1202
pubmed: 28892064
J Biol Chem. 2010 Jul 16;285(29):22576-91
pubmed: 20452972
Cold Spring Harb Perspect Biol. 2017 May 1;9(5):
pubmed: 27881449
Cell. 2013 Sep 12;154(6):1380-9
pubmed: 23992846
Mol Cell Biol. 2003 Nov;23(22):8137-51
pubmed: 14585973
Oncotarget. 2016 Mar 1;7(9):9975-92
pubmed: 26862738
Cancer Res. 2016 May 15;76(10):3088-96
pubmed: 27020858
Am J Physiol Renal Physiol. 2013 May 15;304(10):F1283-94
pubmed: 23515720
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3410-5
pubmed: 11248092
J Clin Invest. 2013 Dec;123(12):5212-30
pubmed: 24200693
Annu Rev Pharmacol Toxicol. 2007;47:89-116
pubmed: 16968214
Free Radic Biol Med. 2015 Nov;88(Pt B):108-146
pubmed: 26122708
Mol Cell Biol. 2013 Jun;33(12):2436-46
pubmed: 23589329
Autophagy. 2016 Oct 2;12(10):1902-1916
pubmed: 27427974
Cancer Cell. 2018 Jul 9;34(1):21-43
pubmed: 29731393
Nature. 2012 Mar 18;484(7392):125-9
pubmed: 22425997
Nat Genet. 2003 Nov;35(3):238-45
pubmed: 14517554
Nature. 2010 Aug 12;466(7308):869-73
pubmed: 20668451
Sci Rep. 2016 Jan 05;6:18760
pubmed: 26729554
Mol Carcinog. 2017 Jun;56(6):1543-1553
pubmed: 28112439
Free Radic Biol Med. 2014 Feb;67:69-80
pubmed: 24140708
PLoS Med. 2006 Oct;3(10):e420
pubmed: 17020408
Oncogene. 2017 Sep 28;36(39):5544-5550
pubmed: 28581526
Cell Mol Life Sci. 2013 Oct;70(20):3893-905
pubmed: 23475109
Nature. 2014 Jan 23;505(7484):495-501
pubmed: 24390350
Pharmacol Res. 2008 Nov-Dec;58(5-6):262-70
pubmed: 18838122
Nature. 2011 Jul 06;475(7354):106-9
pubmed: 21734707
Nat Cell Biol. 2011 Apr;13(4):340-2
pubmed: 21460803
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14132-7
pubmed: 19666565
Nature. 2013 Feb 28;494(7438):484-8
pubmed: 23446420
Sci Transl Med. 2016 Apr 13;8(334):334ra51
pubmed: 27075625
EMBO J. 2016 Apr 15;35(8):803-19
pubmed: 26929011
Cell. 2016 Aug 11;166(4):963-976
pubmed: 27477511
Nat Genet. 2015 Dec;47(12):1475-81
pubmed: 26482881
Cell. 2015 Feb 26;160(5):963-976
pubmed: 25723170
Nat Cell Biol. 2011 Apr;13(4):351-60
pubmed: 21394081
Sci Rep. 2019 Sep 25;9(1):13896
pubmed: 31554934
Trends Cell Biol. 2017 Feb;27(2):126-140
pubmed: 27634431
Dev Cell. 2016 Aug 22;38(4):333-44
pubmed: 27554855
Cell Chem Biol. 2017 Mar 16;24(3):252-280
pubmed: 28286127
Trends Biochem Sci. 2016 Sep;41(9):784-797
pubmed: 27364476
Trends Biochem Sci. 2014 Apr;39(4):199-218
pubmed: 24647116
Nat Cell Biol. 2016 Apr;18(4):418-30
pubmed: 26999738
Nat Rev Cancer. 2018 Aug;18(8):511-524
pubmed: 29802351
Dev Cell. 2008 Dec;15(6):801-12
pubmed: 19081070
Mol Cancer. 2016 Mar 18;15:24
pubmed: 26988232
Nature. 2012 Sep 27;489(7417):519-25
pubmed: 22960745
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13644-9
pubmed: 22864913
Cancer Res. 2013 Jul 1;73(13):4158-68
pubmed: 23610445
Nature. 2013 Oct 10;502(7470):254-7
pubmed: 24089205
Cancer Res. 2006 Jul 1;66(13):6463-7
pubmed: 16818613